NCT05395910View on ClinicalTrials.gov

Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) and Electrostatic PIPAC (ePIPAC) With Paclitaxel In Patients With Peritoneal Carcinomatosis

PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 4, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Peritoneal Carcinomatosis

Interventions

DRUG

Paclitaxel

This is a prospective, two armed phase I trial in a 3 + 3 dose escalation evaluating the safety and tolerability of PIPAC/ePIPAC using paclitaxel in patients with peritoneal carcinomatosis.

Trial Locations (1)

119228

RECRUITING

National University Hospital, Singapore

All Listed Sponsors

lead

National University Hospital, Singapore

OTHER